Cara Therapeutics Inc. (CARA): Qarzning balans kapitallashuviga nisbati

Cara Therapeutics (CARA) grafik logotipi

Cara Therapeutics, Inc. (CARA) kompaniyasining balans hisobotidagi moliyaviy leveraji buyrak yetishmovchiligidan aziyat chekuvchi bemorlar uchun qichishishga qarshi davolash vositalarini ishlab chiquvchi ushbu kompaniyaning barqarorligini baholashga yordam beradi. Dori vositalarini nefrologik parvarishga integratsiya qilish bemorlarning hayot sifatini yaxshilasa-da, klinik sinovlarning to'xtatilishi operatsion faoliyatning qisqarishiga olib keldi. 0.02 qiymati joriy qarz yuklamasining bazaviy ko'rsatkichi bo'lib xizmat qiladi va aktivlarning bozor qiymati prizmasi orqali qarz mablag'larining ulushini kuzatish imkonini beradi.

CARA Cara Therapeutics Inc: Balans qiymatiga qarzlar 04.07.2022 - 30.10.2026 oraligʻida
Cara Therapeutics, Inc tovar namunasi

Ushbu ko'rsatkich biznesning o'z kapitaliga nisbatan qarz mablag'lariga bog'liqligini o'lchaydi. Ko'rsatkichning oshishi moliyaviy barqarorlikning pasayishi va bankrotlik xatarlarining ortishidan dalolat beradi. Jami majburiyatlarning kitob kapitalizatsiyasiga nisbatini tahlil qilish orqali investor kompaniyaning xavfsizlik zaxirasini baholaydi. Bu Cara Therapeutics, Inc. (CARA) uchun juda muhimdir, chunki klinik dasturlarning to'xtab qolishi operatsion dinamikani zaiflashtiradi. Jori royalti to'lovlari yangi moliyalashtirish manbalariga bo'lgan ehtiyojni faqat vaqtincha yashiradi.

Cara Therapeutics, Inc. raqobatchilari

Biogen Inc. - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar neurocrine.com NBIX|RGC - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati AXSM (Axsome)|ACADIA Pharmaceuticals Inc (ACAD) - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar Xenon Corp (XENE)|VKTX (Viking Therapeutics) - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati supernus.com (SUPN)|Balans kapitallashuviga qarzlar CPRX|Balans kapitallashuviga qarzlar Denali (DNLI)|Qarzning balans kapitallashuviga nisbati Harmony Pharma HRMY|Qarzning sof aktivlarga nisbati BHVN|Amylyx Pharmaceuticals - Balans kapitallashuviga qarzlar|TRVI - Balans kapitallashuviga qarzlar|PRAX (Praxis Precision Medicines, Inc.) - Qarzning balans qiymatiga nisbati|Anavex - Qarzning sof aktivlarga nisbati|Qarzning balans qiymatiga nisbati CBLL|PRTA (prothena.com) - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar ALEC|ANNX (annexonbio.com) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar OMER (Omeros)|Neurogene Inc (NGNE) - Balans qiymatiga qarzlar|ACIU - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati VYGR (Voyager Corp)|NMRA: Balans kapitallashuviga qarzlar|scilexholding.com (SCLX) - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Tevogen Bio|Alpha Cognition Corp - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar CGTX|IKT - Balans qiymatiga qarzlar|Cassava Sciences, Inc. - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar Assertio Holdings ASRT|COYA: Qarzning balans qiymatiga nisbati|Vistagen Therapeutics - Qarzning balans kapitaliga nisbati|OVID: Balans kapitallashuviga qarzlar|ABOS - Sof aktivlarga qarzlar|CRVO (CervoMed Inc.) - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Alterity Therapeutics Ltd (ATHE)|Qarzning balans kapitallashuviga nisbati Clene Inc. (CLNN)|Sof aktivlarga qarzlar pepgen.com|Jupiter Neurosciences Inc - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati RLMD|Annovis Bio, Inc. - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar Grace Therapeutics, Inc. GRCE|Firefly Neuroscience (AIFF) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati KLTO|NRSN (NeuroSense Therapeutics Ltd) - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Reviva Pharmaceuticals, Inc. (RVPH)|Qarzning balans qiymatiga nisbati MTVA (MetaVia Inc)|Sof aktivlarga qarzlar neuraxis.com|Balans kapitallashuviga qarzlar HSDT (Helius Medical Technologies)|PASG - Qarzning balans qiymatiga nisbati|Neuphoria - Balans kapitallashuviga qarzlar|NERV - Balans kapitallashuviga qarzlar|Athira Pharma, Inc. (ATHA) - Qarzning balans kapitallashuviga nisbati|addextherapeutics.com - Qarzning sof aktivlarga nisbati|ALZN (Alzamend Neuro Inc.) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar Cyclerion|Qarzning balans kapitallashuviga nisbati Protagenic Therapeutics (PTIX)|pasitheaclinics.com - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar CRGT (Cortigent)|avenuetx.com (ATXI) - Balans qiymatiga qarzlar|BCLI: Qarzning balans qiymatiga nisbati|CHRO - Balans kapitallashuviga qarzlar|eliemtx.com (ELYM) - Qarzning balans kapitallashuviga nisbati|Intra-Cellular Therapies, Inc. - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Longboard Pharmaceuticals|Balans qiymatiga qarzlar marinuspharma.com MRNS|Balans kapitallashuviga qarzlar NKGN|Qarzning balans qiymatiga nisbati NeuroBo Pharmaceuticals Inc NRBO|Balans kapitallashuviga qarzlar SAGE (Sage Therapeutics, Inc)|Balans kapitallashuviga qarzlar Synaptogenix, Inc SNPX|TRVN - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati VIGL (Vigil Neuroscience)|WENA: Balans kapitallashuviga qarzlar|Cerevel Therapeutics Inc (CERE) - Balans kapitallashuviga qarzlar